Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
12,760,409
-
Share change
-
+165,825
-
Total reported value
-
$597,075,030
-
Put/Call ratio
-
30%
-
Price per share
-
$46.80
-
Number of holders
-
119
-
Value change
-
+$18,418,324
-
Number of buys
-
66
-
Number of sells
-
45
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q3 2017
As of 30 Sep 2017,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,760,409 shares.
The largest 10 holders included
BlackRock Inc., Krensavage Asset Management, LLC, FIRST MANHATTAN CO, VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, FARALLON CAPITAL MANAGEMENT LLC, and Stonepine Capital Management, LLC.
This page lists
120
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.